首页 > 最新文献

Health Services Research最新文献

英文 中文
The Impact of Provider Productivity on Suicide-Related Events Among Veterans. 提供者生产力对退伍军人自杀相关事件的影响。
IF 3.2 2区 医学 Q2 HEALTH CARE SCIENCES & SERVICES Pub Date : 2026-02-01 Epub Date: 2025-07-09 DOI: 10.1111/1475-6773.70008
Kiersten L Strombotne, Daniel Lipsey, Fernando Mattar, Kathleen Carey, Samantha G Auty, Brian W Stanley, Steven D Pizer

Objective: To examine the relationship between mental health provider productivity, staffing levels, and suicide-related events (SREs) among U.S. Veterans receiving care within the Veterans Health Administration (VHA), focusing on therapy and medication management providers.

Data sources/setting: We analyzed administrative data from the Department of Defense and VHA (2014-2018), encompassing 109,376 Veterans who separated from active duty between 2010 and 2017.

Design: A longitudinal design estimated the effects of facility-level provider work rate and staffing on SREs, adjusting for patient and facility characteristics. An instrumental variables (IV) approach addressed potential endogeneity.

Data collection/extraction methods: Data were obtained from the VHA Corporate Data Warehouse and the VHA Survey of Enrollees.

Principal findings: A 1% increase in therapy provider work rate led to a 12.1% increase in SRE probability, regardless of staffing levels. Conversely, a 1% increase in staffing levels led to a 1.6% reduction in SREs, with the largest effect in low-staffed facilities. For medication management providers, work rate had no overall impact on SREs, except in medium-staffed facilities. A 1% increase in staffing levels for medication management providers led to a 1.7% reduction in SREs.

Conclusions: Increased work rates, particularly in low-staffed VHA facilities, may elevate suicide-related risks. In contrast, staffing increases simultaneously improve access and reduce adverse outcomes. Where possible, policymakers should prioritize staffing growth over productivity gains to improve access to mental health clinics and ensure Veteran safety and care quality.

目的:探讨在退伍军人健康管理局(VHA)接受治疗的美国退伍军人中,心理健康提供者的工作效率、人员配备水平和自杀相关事件(SREs)之间的关系,重点是治疗和药物管理提供者。数据来源/设置:我们分析了国防部和VHA(2014-2018)的行政数据,其中包括2010年至2017年期间退出现役的109,376名退伍军人。设计:纵向设计评估了医疗机构工作效率和人员配置对SREs的影响,并根据患者和医疗机构的特点进行了调整。工具变量(IV)方法解决了潜在的内生性。数据收集/提取方法:数据来自VHA企业数据仓库和VHA参保人调查。主要发现:无论人员配备水平如何,治疗提供者工作率增加1%导致SRE概率增加12.1%。相反,人员配备水平每增加1%,SREs就会减少1.6%,对人员配备不足的设施影响最大。对于药物管理提供者来说,工作效率对SREs没有总体影响,除了中等人员配备的设施。药物管理提供者的人员配备水平每增加1%,SREs就会减少1.7%。结论:增加的工作率,特别是在人手不足的VHA设施,可能会增加自杀相关的风险。相比之下,人员配备的增加同时改善了可及性并减少了不良后果。在可能的情况下,决策者应优先考虑增加人员而不是提高生产力,以改善精神卫生诊所的服务,并确保退伍军人的安全和护理质量。
{"title":"The Impact of Provider Productivity on Suicide-Related Events Among Veterans.","authors":"Kiersten L Strombotne, Daniel Lipsey, Fernando Mattar, Kathleen Carey, Samantha G Auty, Brian W Stanley, Steven D Pizer","doi":"10.1111/1475-6773.70008","DOIUrl":"10.1111/1475-6773.70008","url":null,"abstract":"<p><strong>Objective: </strong>To examine the relationship between mental health provider productivity, staffing levels, and suicide-related events (SREs) among U.S. Veterans receiving care within the Veterans Health Administration (VHA), focusing on therapy and medication management providers.</p><p><strong>Data sources/setting: </strong>We analyzed administrative data from the Department of Defense and VHA (2014-2018), encompassing 109,376 Veterans who separated from active duty between 2010 and 2017.</p><p><strong>Design: </strong>A longitudinal design estimated the effects of facility-level provider work rate and staffing on SREs, adjusting for patient and facility characteristics. An instrumental variables (IV) approach addressed potential endogeneity.</p><p><strong>Data collection/extraction methods: </strong>Data were obtained from the VHA Corporate Data Warehouse and the VHA Survey of Enrollees.</p><p><strong>Principal findings: </strong>A 1% increase in therapy provider work rate led to a 12.1% increase in SRE probability, regardless of staffing levels. Conversely, a 1% increase in staffing levels led to a 1.6% reduction in SREs, with the largest effect in low-staffed facilities. For medication management providers, work rate had no overall impact on SREs, except in medium-staffed facilities. A 1% increase in staffing levels for medication management providers led to a 1.7% reduction in SREs.</p><p><strong>Conclusions: </strong>Increased work rates, particularly in low-staffed VHA facilities, may elevate suicide-related risks. In contrast, staffing increases simultaneously improve access and reduce adverse outcomes. Where possible, policymakers should prioritize staffing growth over productivity gains to improve access to mental health clinics and ensure Veteran safety and care quality.</p>","PeriodicalId":55065,"journal":{"name":"Health Services Research","volume":" ","pages":"e70008"},"PeriodicalIF":3.2,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12857439/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144602296","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring the Early Effects of State Consumer Protection Policies on Medical Debt in Collections. 探索国家消费者保护政策对医疗债务催收的早期影响。
IF 3.2 2区 医学 Q2 HEALTH CARE SCIENCES & SERVICES Pub Date : 2026-02-01 Epub Date: 2025-11-17 DOI: 10.1111/1475-6773.70068
Fredric Blavin, Breno Braga, Michael Karpman, Dulce Gonzalez, Maanasa Kona

Objective: To test if state consumer protection policies reduce the share of consumers with medical debt in collections on their credit reports.

Study setting and design: This study uses a quasi-experimental research design to estimate the impact of consumer protection laws implemented between 2020 and 2022 in Illinois, Maryland, New Mexico, and Oregon on the share of consumers with medical debt in collections. These laws primarily aim to protect consumers against medical debt by expanding access to hospital financial assistance. We use a synthetic control approach to estimate changes in medical debt following the implementation of policies in treatment states relative to changes in select control states. We also assess the effects of earlier policies implemented between 2013 and 2019 in Washington, Utah, and North Carolina.

Data sources and analytic sample: This analysis relies on two extracts of credit bureau data from one of the country's three main credit bureau agencies. The first extract consists of random samples from June 2017 to June 2024 of approximately 125,000 consumers in each treatment state and 500,000 residents from the pool of 14 selected comparison states in each year. The second extract is based on a 2%-4% random sample of consumers in each year from 2011 to 2022.

Principal findings: We did not observe a statistically significant reduction in medical debt associated with policies implemented in these states within the study timeframe. In most states in our primary analysis, point estimates of the treatment effects are near zero, and in nearly all state-years, we can only rule out declines in medical debt larger than 1-3 percentage points following policy implementation.

Conclusions: Though we did not detect statistically significant effects of recent consumer protection policies on medical debt in collections, additional research is needed on whether these policies benefited consumers in ways that are not measured in this analysis and whether states that continue to move forward with similar laws can improve their effectiveness by extending consumer protections to a wider group of patients and providers and addressing implementation and enforcement challenges.

目的:检验国家消费者保护政策是否减少了消费者在信用报告中医疗债务的收集份额。研究设置和设计:本研究采用准实验研究设计来估计2020年至2022年在伊利诺伊州、马里兰州、新墨西哥州和俄勒冈州实施的消费者保护法对医疗债务催收消费者比例的影响。这些法律的主要目的是通过扩大获得医院财政援助的机会来保护消费者免受医疗债务的影响。我们使用一种综合控制方法来估计在治疗州实施政策后医疗债务的变化相对于选择控制州的变化。我们还评估了2013年至2019年期间在华盛顿州、犹他州和北卡罗来纳州实施的早期政策的影响。数据来源和分析样本:本分析依赖于来自该国三家主要征信机构之一的征信机构数据的两个摘录。第一个提取由2017年6月至2024年6月的随机样本组成,每个处理州约有12.5万名消费者,每年从14个选定的比较州中抽取50万名居民。第二个提取是基于从2011年到2022年每年2%-4%的随机消费者样本。主要发现:在研究时间框架内,我们没有观察到与这些州实施的政策相关的医疗债务的统计学显著减少。在我们的初步分析中,对大多数州的治疗效果的点估计接近于零,而且在几乎所有州的年份中,我们只能排除在政策实施后医疗债务下降幅度大于1-3个百分点的可能性。结论:虽然我们没有发现最近的消费者保护政策对医疗债务收集的统计显着影响,但需要进一步研究这些政策是否以本分析中未测量的方式使消费者受益,以及继续推进类似法律的州是否可以通过将消费者保护扩展到更广泛的患者和提供者群体并解决实施和执行挑战来提高其有效性。
{"title":"Exploring the Early Effects of State Consumer Protection Policies on Medical Debt in Collections.","authors":"Fredric Blavin, Breno Braga, Michael Karpman, Dulce Gonzalez, Maanasa Kona","doi":"10.1111/1475-6773.70068","DOIUrl":"10.1111/1475-6773.70068","url":null,"abstract":"<p><strong>Objective: </strong>To test if state consumer protection policies reduce the share of consumers with medical debt in collections on their credit reports.</p><p><strong>Study setting and design: </strong>This study uses a quasi-experimental research design to estimate the impact of consumer protection laws implemented between 2020 and 2022 in Illinois, Maryland, New Mexico, and Oregon on the share of consumers with medical debt in collections. These laws primarily aim to protect consumers against medical debt by expanding access to hospital financial assistance. We use a synthetic control approach to estimate changes in medical debt following the implementation of policies in treatment states relative to changes in select control states. We also assess the effects of earlier policies implemented between 2013 and 2019 in Washington, Utah, and North Carolina.</p><p><strong>Data sources and analytic sample: </strong>This analysis relies on two extracts of credit bureau data from one of the country's three main credit bureau agencies. The first extract consists of random samples from June 2017 to June 2024 of approximately 125,000 consumers in each treatment state and 500,000 residents from the pool of 14 selected comparison states in each year. The second extract is based on a 2%-4% random sample of consumers in each year from 2011 to 2022.</p><p><strong>Principal findings: </strong>We did not observe a statistically significant reduction in medical debt associated with policies implemented in these states within the study timeframe. In most states in our primary analysis, point estimates of the treatment effects are near zero, and in nearly all state-years, we can only rule out declines in medical debt larger than 1-3 percentage points following policy implementation.</p><p><strong>Conclusions: </strong>Though we did not detect statistically significant effects of recent consumer protection policies on medical debt in collections, additional research is needed on whether these policies benefited consumers in ways that are not measured in this analysis and whether states that continue to move forward with similar laws can improve their effectiveness by extending consumer protections to a wider group of patients and providers and addressing implementation and enforcement challenges.</p>","PeriodicalId":55065,"journal":{"name":"Health Services Research","volume":" ","pages":"e70068"},"PeriodicalIF":3.2,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12857520/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145544279","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The 340B Drug Pricing Program, Hospital Prices, and Competition in Commercial Markets 340B药品定价计划、医院价格和商业市场竞争。
IF 3.2 2区 医学 Q2 HEALTH CARE SCIENCES & SERVICES Pub Date : 2026-02-01 DOI: 10.1111/1475-6773.70085
Sunita M. Desai, Prianca Padmanabhan, Kyle Smith, Jessica Chang, J. Michael McWilliams

Objective

To examine whether hospital eligibility for the 340b drug pricing program reduces prices for clinician-administered drugs in commercial insurance markets and whether effects vary by market competition.

Study Setting and Design

We conducted a quasi-experimental study using a regression discontinuity design that leverages the federal eligibility threshold for 340B participation (disproportionate share hospital [DSH] percentage > 11.75%). The study included non-profit and public acute care hospitals that billed for clinician-administered drugs in the outpatient setting between 2012 and 2014. The primary outcome was hospital-insurer negotiated unit prices for high-spending outpatient drugs. Secondary outcomes included drug volume and revenue.

Data Sources and Analytic Sample

We analyzed secondary data from the Health Care Cost Institute (HCCI), which includes claims from three national commercial insurers linked to hospital-level characteristics from the Hospital Cost Report Information System (HCRIS) and provider identifiers from the National Plan and Provider Enumeration System (NPPES). The analytic sample comprised 637 hospitals billing 148,037 clinician-administered drug claims for the five drugs with highest total spending.

Principal Findings

Hospital 340B eligibility was associated with a $605 reduction (95% CI: −934 to −276) in median unit drug prices, a 25% decrease relative to the mean price among ineligible hospitals at the threshold ($2387). Effects were concentrated in competitive markets (Herfindahl–Hirschman Index [HHI] ≤ 1800), where eligibility was associated with a $793 reduction (95% CI: −1197 to −388), a 32% decrease. In highly concentrated markets, effects were small and statistically insignificant. Price reductions were offset by non-significant increases in drug volume (25%) and neutral effects on drug revenue.

Conclusions

Hospital 340B eligibility reduced commercial drug prices only in competitive markets. These findings suggest that market competition is critical for ensuring that policy-driven hospital cost savings are shared with payers and patients.

目的:考察医院参与340b药品定价计划是否降低了商业保险市场上临床用药的价格,以及这种效果是否因市场竞争而异。研究设置和设计:我们使用回归不连续设计进行了一项准实验研究,该设计利用了340B参与的联邦资格门槛(不成比例份额医院[DSH]百分比> 11.75%)。该研究包括2012年至2014年期间在门诊环境中为临床用药收费的非营利和公立急症护理医院。主要结果是医院与保险公司协商的高支出门诊药物的单价。次要结局包括药物量和收入。数据来源和分析样本:我们分析了来自卫生保健成本研究所(HCCI)的二手数据,其中包括来自三家国家商业保险公司的索赔,这些索赔与医院成本报告信息系统(HCRIS)中的医院级特征相关,以及来自国家计划和提供者计数系统(NPPES)的提供者标识符。分析样本包括637家医院,对总支出最高的五种药物进行了148,037次临床用药索赔。主要发现:符合340B条件的医院单位药品价格中位数降低了605美元(95% CI: -934至-276),相对于不符合条件的医院在门槛处的平均价格(2387美元)降低了25%。效果集中在竞争市场(赫芬达尔-赫希曼指数[HHI]≤1800),其中资格与793美元的减少相关(95% CI: -1197至-388),减少32%。在高度集中的市场中,影响很小,统计上不显著。价格下降被药品数量的不显著增加(25%)和对药品收入的中性影响所抵消。结论:医院340B资格仅在竞争性市场中降低了商品药品价格。这些研究结果表明,市场竞争对于确保由政策驱动的医院成本节约惠及支付方和患者至关重要。
{"title":"The 340B Drug Pricing Program, Hospital Prices, and Competition in Commercial Markets","authors":"Sunita M. Desai,&nbsp;Prianca Padmanabhan,&nbsp;Kyle Smith,&nbsp;Jessica Chang,&nbsp;J. Michael McWilliams","doi":"10.1111/1475-6773.70085","DOIUrl":"10.1111/1475-6773.70085","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>To examine whether hospital eligibility for the 340b drug pricing program reduces prices for clinician-administered drugs in commercial insurance markets and whether effects vary by market competition.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Study Setting and Design</h3>\u0000 \u0000 <p>We conducted a quasi-experimental study using a regression discontinuity design that leverages the federal eligibility threshold for 340B participation (disproportionate share hospital [DSH] percentage &gt; 11.75%). The study included non-profit and public acute care hospitals that billed for clinician-administered drugs in the outpatient setting between 2012 and 2014. The primary outcome was hospital-insurer negotiated unit prices for high-spending outpatient drugs. Secondary outcomes included drug volume and revenue.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Data Sources and Analytic Sample</h3>\u0000 \u0000 <p>We analyzed secondary data from the Health Care Cost Institute (HCCI), which includes claims from three national commercial insurers linked to hospital-level characteristics from the Hospital Cost Report Information System (HCRIS) and provider identifiers from the National Plan and Provider Enumeration System (NPPES). The analytic sample comprised 637 hospitals billing 148,037 clinician-administered drug claims for the five drugs with highest total spending.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Principal Findings</h3>\u0000 \u0000 <p>Hospital 340B eligibility was associated with a $605 reduction (95% CI: −934 to −276) in median unit drug prices, a 25% decrease relative to the mean price among ineligible hospitals at the threshold ($2387). Effects were concentrated in competitive markets (Herfindahl–Hirschman Index [HHI] ≤ 1800), where eligibility was associated with a $793 reduction (95% CI: −1197 to −388), a 32% decrease. In highly concentrated markets, effects were small and statistically insignificant. Price reductions were offset by non-significant increases in drug volume (25%) and neutral effects on drug revenue.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Hospital 340B eligibility reduced commercial drug prices only in competitive markets. These findings suggest that market competition is critical for ensuring that policy-driven hospital cost savings are shared with payers and patients.</p>\u0000 </section>\u0000 </div>","PeriodicalId":55065,"journal":{"name":"Health Services Research","volume":"61 1","pages":""},"PeriodicalIF":3.2,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146101131","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Impacts of 1115 Medicaid Substance Use Disorder Waivers on Medicaid-Paid Use of Residential Treatment and Other Types of Services in 20 States. 1115医疗补助物质使用障碍豁免对20个州医疗补助支付的住院治疗和其他类型服务的影响。
IF 3.2 2区 医学 Q2 HEALTH CARE SCIENCES & SERVICES Pub Date : 2026-02-01 Epub Date: 2025-08-06 DOI: 10.1111/1475-6773.70022
Stephan R Lindner, Kyle Hart, Brynna Manibusan, Kirbee A Johnston, Dennis McCarty, K John McConnell

Objective: To assess the association between the implementation of 1115 Medicaid substance use disorder (SUD) waivers and changes in Medicaid-paid use of residential treatment and other types of services.

Study setting and design: We compared 20 states with SUD waivers to 14 non-waiver states using a staggered difference-in-differences design. Primary outcomes were Medicaid-paid opioid-use disorder (OUD) related residential treatment stays and length of stay (LOS). Secondary outcomes included admissions and LOS for all-cause and OUD-related inpatient stays, psychiatric hospital admissions, emergency department (ED) visits, outpatient visits, and primary care visits.

Data source and analytic sample: We used the 2016-2021 Transformed Medicaid Statistical Information System (T-MSIS) Analytic Files (TAF). The analytic sample included Medicaid enrollees ages 18-64 with OUD.

Principal findings: On average, waiver implementation was associated with an increase in residential treatment stays (estimate: 0.4%; 95% CI: 0.1%-0.7%), OUD-related inpatient visits LOS (estimate: 0.3 days; 95% CI: 0.0%-0.5%), psychiatric hospital LOS (estimate: 1.0 days; 95% CI: 0.6 days-1.4 days), primary care visits (estimate: 3.0%; 95% CI: 1.2%-4.7%), and OUD-related primary care visits (estimate: 2.7%; 95% CI: 0.9%-4.4%); and a decline in all-cause inpatient visits (estimate: -0.9%; 95% CI: -1.9% to -0.0%) and OUD-related inpatient visits (estimate: -0.8%; 95% CI: -1.6% to -0.0%). Results for psychiatric hospital LOS and OUD-related primary care visits were sensitive to adjusting for pre-trends. Among four early-adopting states (Indiana, Louisiana, New Jersey, Virginia), Medicaid-paid residential treatment increased 1-4 years following waiver implementation (e.g., 2-year estimate: 2.8%, 95% CI: 2.5%-3.0%), and inpatient visits declined 1-4 years following waiver implementation (e.g., 2-year estimate: -3.1%, 95% CI: -3.5% to -2.6%).

Conclusions: SUD waivers were associated with a small increase in Medicaid-paid residential treatment and a decline in inpatient visits across states, with changes being concentrated among early-adopting states.

目的:评估1115医疗补助物质使用障碍(SUD)豁免的实施与医疗补助支付的住院治疗和其他类型服务使用变化之间的关系。研究设置和设计:我们使用交错差异设计比较了20个豁免SUD的州和14个非豁免SUD的州。主要结局是医疗补助支付的阿片类药物使用障碍(OUD)相关的住院治疗时间和住院时间(LOS)。次要结局包括全因和oud相关住院的住院率和LOS、精神病院住院率、急诊科(ED)就诊、门诊就诊和初级保健就诊。数据来源和分析样本:我们使用2016-2021年转化医疗补助统计信息系统(T-MSIS)分析文件(TAF)。分析样本包括18-64岁患有OUD的医疗补助入选者。主要发现:平均而言,豁免的实施与住院治疗时间的增加有关(估计:0.4%;95% CI: 0.1%-0.7%),与oud相关的住院就诊LOS(估计:0.3天;95% CI: 0.0%-0.5%),精神病院LOS(估计:1.0天;95% CI: 0.6 -1.4天),初级保健就诊(估计:3.0%;95% CI: 1.2%-4.7%),以及与oud相关的初级保健就诊(估计:2.7%;95% ci: 0.9%-4.4%);全因住院人数下降(估计:-0.9%;95% CI: -1.9%至-0.0%)和与oud相关的住院患者就诊(估计:-0.8%;95% CI: -1.6% ~ -0.0%)。精神病院LOS和oud相关初级保健访视的结果对调整前趋势敏感。在四个早期采用的州(印第安纳州,路易斯安那州,新泽西州,弗吉尼亚州),医疗补助支付的住院治疗在豁免实施后的1-4年内增加(例如,2年估计:2.8%,95% CI: 2.5%-3.0%),住院患者就诊在豁免实施后的1-4年内下降(例如,2年估计:-3.1%,95% CI: -3.5%至-2.6%)。结论:SUD豁免与各州医疗补助支付的住院治疗的小幅增加和住院就诊的减少有关,变化集中在早期采用的州。
{"title":"The Impacts of 1115 Medicaid Substance Use Disorder Waivers on Medicaid-Paid Use of Residential Treatment and Other Types of Services in 20 States.","authors":"Stephan R Lindner, Kyle Hart, Brynna Manibusan, Kirbee A Johnston, Dennis McCarty, K John McConnell","doi":"10.1111/1475-6773.70022","DOIUrl":"10.1111/1475-6773.70022","url":null,"abstract":"<p><strong>Objective: </strong>To assess the association between the implementation of 1115 Medicaid substance use disorder (SUD) waivers and changes in Medicaid-paid use of residential treatment and other types of services.</p><p><strong>Study setting and design: </strong>We compared 20 states with SUD waivers to 14 non-waiver states using a staggered difference-in-differences design. Primary outcomes were Medicaid-paid opioid-use disorder (OUD) related residential treatment stays and length of stay (LOS). Secondary outcomes included admissions and LOS for all-cause and OUD-related inpatient stays, psychiatric hospital admissions, emergency department (ED) visits, outpatient visits, and primary care visits.</p><p><strong>Data source and analytic sample: </strong>We used the 2016-2021 Transformed Medicaid Statistical Information System (T-MSIS) Analytic Files (TAF). The analytic sample included Medicaid enrollees ages 18-64 with OUD.</p><p><strong>Principal findings: </strong>On average, waiver implementation was associated with an increase in residential treatment stays (estimate: 0.4%; 95% CI: 0.1%-0.7%), OUD-related inpatient visits LOS (estimate: 0.3 days; 95% CI: 0.0%-0.5%), psychiatric hospital LOS (estimate: 1.0 days; 95% CI: 0.6 days-1.4 days), primary care visits (estimate: 3.0%; 95% CI: 1.2%-4.7%), and OUD-related primary care visits (estimate: 2.7%; 95% CI: 0.9%-4.4%); and a decline in all-cause inpatient visits (estimate: -0.9%; 95% CI: -1.9% to -0.0%) and OUD-related inpatient visits (estimate: -0.8%; 95% CI: -1.6% to -0.0%). Results for psychiatric hospital LOS and OUD-related primary care visits were sensitive to adjusting for pre-trends. Among four early-adopting states (Indiana, Louisiana, New Jersey, Virginia), Medicaid-paid residential treatment increased 1-4 years following waiver implementation (e.g., 2-year estimate: 2.8%, 95% CI: 2.5%-3.0%), and inpatient visits declined 1-4 years following waiver implementation (e.g., 2-year estimate: -3.1%, 95% CI: -3.5% to -2.6%).</p><p><strong>Conclusions: </strong>SUD waivers were associated with a small increase in Medicaid-paid residential treatment and a decline in inpatient visits across states, with changes being concentrated among early-adopting states.</p>","PeriodicalId":55065,"journal":{"name":"Health Services Research","volume":" ","pages":"1-9"},"PeriodicalIF":3.2,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12377293/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144790777","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Impact of Increased Medicaid Eligibility During Pregnancy on Medicaid Utilization and Gestational Age. 怀孕期间增加医疗补助资格对医疗补助利用和胎龄的影响。
IF 3.2 2区 医学 Q2 HEALTH CARE SCIENCES & SERVICES Pub Date : 2026-02-01 Epub Date: 2025-09-14 DOI: 10.1111/1475-6773.70037
Nicolas P Goldstein Novick, Peter J Veazie, Elaine L Hill, Eva K Pressman, Peter G Szilagyi, Timothy D Nelin, Scott A Lorch

Objective: To assess the impact of increased Medicaid income eligibility during pregnancy on payment source for prenatal care and birth and on gestational age at birth (GAb).

Study setting and design: We performed a quasi-experimental, difference-in-differences study comparing two increases in Medicaid income eligibility during pregnancy to two control states with data from 2007 to 2010: (Dyad 1) Ohio (expanded from 150% to 200% of the Federal Poverty level [FPL]) versus Pennsylvania and (Dyad 2) Wisconsin (185% to 250% FPL) versus Michigan. We performed multinomial logistic regression to assess the impact of increased Medicaid eligibility on the following key outcome variables: payment source for prenatal care and birth and GAb.

Data sources and analytic sample: We utilized CDC Pregnancy Risk Assessment Monitoring System (PRAMS) data (2007-2010) and limited analysis to singleton, in-state live births. After re-weighting for PRAMS survey design, our analytical sample represented about 540,000 births.

Principal findings: In the higher-income Wisconsin-Michigan dyad, increased Medicaid eligibility during pregnancy significantly increased exclusive Medicaid coverage for prenatal care (7.0%, 95% CI 2.9% to 11.1%) and birth (8.3%, 4.3% to 12.4%). Simultaneously, private insurance coverage dropped for prenatal care (-4.0%, -7.7% to -0.3%) and birth (-3.7%, -7.2% to -0.2%) while self-payment decreased only for birth (-1.8%, -3.5% to -0.2%). In the lower-income Ohio-Pennsylvania dyad, the only statistically significant effects on payment source were decreases in the likelihood of a payment source of other for prenatal care (-3.3%, -6.2% to -0.3%) and birth (-4.7%, -7.9% to -1.6%). There were no statistically significant effects on GAb across both dyads.

Conclusions: Increased Medicaid eligibility during pregnancy for individuals of higher income seems to improve utilization of exclusive Medicaid with diminished uninsurance but also less private insurance after accounting for indicators of socioeconomic advantage but has no clear impact on GAb. Medicaid policy should balance reducing uninsurance with directing scarce resources to high-risk individuals.

目的:评估孕期医疗补助收入资格增加对产前护理和分娩支付来源以及出生胎龄(GAb)的影响。研究设置和设计:我们进行了一项准实验,差异中差异研究,比较了两个对照州在怀孕期间医疗补助收入资格的两次增加,数据来自2007年至2010年:(Dyad 1)俄亥俄州(从联邦贫困水平[FPL]的150%扩大到200%)与宾夕法尼亚州和(Dyad 2)威斯康星州(从185%扩大到250% FPL)与密歇根州。我们使用多项逻辑回归来评估增加医疗补助资格对以下关键结果变量的影响:产前护理和分娩的支付来源和GAb。数据来源和分析样本:我们使用疾病预防控制中心妊娠风险评估监测系统(PRAMS)数据(2007-2010年),并对单胎和州内活产婴儿进行有限分析。在对PRAMS调查设计重新加权后,我们的分析样本代表了大约54万名新生儿。主要发现:在高收入的威斯康辛-密歇根双组中,怀孕期间医疗补助资格的增加显著增加了产前护理(7.0%,95% CI 2.9%至11.1%)和分娩(8.3%,4.3%至12.4%)的独家医疗补助覆盖率。与此同时,私人保险的产前护理(-4.0%,-7.7%,-0.3%)和生育(-3.7%,-7.2%,-0.2%)的保险覆盖率有所下降,而自付保险的保险覆盖率只有生育(-1.8%,-3.5%,-0.2%)有所下降。在收入较低的俄亥俄州和宾夕法尼亚州,对支付来源的唯一统计显著影响是产前护理(-3.3%,-6.2%至-0.3%)和分娩(-4.7%,-7.9%至-1.6%)的其他支付来源的可能性降低。在两对夫妇中,GAb没有统计学上的显著影响。结论:考虑到社会经济优势指标后,高收入个体怀孕期间医疗补助资格的增加似乎提高了独家医疗补助的利用率,减少了不保险,但也减少了私人保险,但对GAb没有明显影响。医疗补助政策应该在减少无保险和将稀缺资源导向高风险人群之间取得平衡。
{"title":"The Impact of Increased Medicaid Eligibility During Pregnancy on Medicaid Utilization and Gestational Age.","authors":"Nicolas P Goldstein Novick, Peter J Veazie, Elaine L Hill, Eva K Pressman, Peter G Szilagyi, Timothy D Nelin, Scott A Lorch","doi":"10.1111/1475-6773.70037","DOIUrl":"10.1111/1475-6773.70037","url":null,"abstract":"<p><strong>Objective: </strong>To assess the impact of increased Medicaid income eligibility during pregnancy on payment source for prenatal care and birth and on gestational age at birth (GAb).</p><p><strong>Study setting and design: </strong>We performed a quasi-experimental, difference-in-differences study comparing two increases in Medicaid income eligibility during pregnancy to two control states with data from 2007 to 2010: (Dyad 1) Ohio (expanded from 150% to 200% of the Federal Poverty level [FPL]) versus Pennsylvania and (Dyad 2) Wisconsin (185% to 250% FPL) versus Michigan. We performed multinomial logistic regression to assess the impact of increased Medicaid eligibility on the following key outcome variables: payment source for prenatal care and birth and GAb.</p><p><strong>Data sources and analytic sample: </strong>We utilized CDC Pregnancy Risk Assessment Monitoring System (PRAMS) data (2007-2010) and limited analysis to singleton, in-state live births. After re-weighting for PRAMS survey design, our analytical sample represented about 540,000 births.</p><p><strong>Principal findings: </strong>In the higher-income Wisconsin-Michigan dyad, increased Medicaid eligibility during pregnancy significantly increased exclusive Medicaid coverage for prenatal care (7.0%, 95% CI 2.9% to 11.1%) and birth (8.3%, 4.3% to 12.4%). Simultaneously, private insurance coverage dropped for prenatal care (-4.0%, -7.7% to -0.3%) and birth (-3.7%, -7.2% to -0.2%) while self-payment decreased only for birth (-1.8%, -3.5% to -0.2%). In the lower-income Ohio-Pennsylvania dyad, the only statistically significant effects on payment source were decreases in the likelihood of a payment source of other for prenatal care (-3.3%, -6.2% to -0.3%) and birth (-4.7%, -7.9% to -1.6%). There were no statistically significant effects on GAb across both dyads.</p><p><strong>Conclusions: </strong>Increased Medicaid eligibility during pregnancy for individuals of higher income seems to improve utilization of exclusive Medicaid with diminished uninsurance but also less private insurance after accounting for indicators of socioeconomic advantage but has no clear impact on GAb. Medicaid policy should balance reducing uninsurance with directing scarce resources to high-risk individuals.</p>","PeriodicalId":55065,"journal":{"name":"Health Services Research","volume":" ","pages":"e70037"},"PeriodicalIF":3.2,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12857488/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145066230","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction to "Cross Country Comparisons in Price Growth Over Time". 修正“长期价格增长的跨国比较”。
IF 3.2 2区 医学 Q2 HEALTH CARE SCIENCES & SERVICES Pub Date : 2026-02-01 Epub Date: 2025-10-01 DOI: 10.1111/1475-6773.70047
{"title":"Correction to \"Cross Country Comparisons in Price Growth Over Time\".","authors":"","doi":"10.1111/1475-6773.70047","DOIUrl":"10.1111/1475-6773.70047","url":null,"abstract":"","PeriodicalId":55065,"journal":{"name":"Health Services Research","volume":" ","pages":"e70047"},"PeriodicalIF":3.2,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12857473/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145208222","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk of Hospital Readmissions and Association With Receipt of Post-Hospitalization Care Coordination Services Among High-Risk Veterans. 高危退伍军人再入院风险与接受住院后护理协调服务的关系
IF 3.2 2区 医学 Q2 HEALTH CARE SCIENCES & SERVICES Pub Date : 2026-02-01 Epub Date: 2025-09-26 DOI: 10.1111/1475-6773.70044
Diana J Govier, Meike Niederhausen, Alex Hickok, Mazhgan Rowneki, Holly McCready, Abby Moss, Kristina M Cordasco, Kathryn M McDonald, Matthew L Maciejewski, Kathleen C Thomas, Denise M Hynes

Objective: To examine associations between receipt of post-hospitalization care coordination and VA-delivered, VA-purchased, and Medicare fee-for-service hospital readmissions among Veterans at high risk for hospitalization and/or mortality.

Study setting and design: In this observational retrospective cohort study, we compared high-risk Veterans who received care coordination within one day after hospital discharge ("treated") with up to five matched high-risk Veterans who did not receive care coordination during this time ("comparators"). Competing risk models estimated adjusted sub-hazard ratios (aSHR) for 30-day all-cause and ambulatory care sensitive condition (ACSC) readmissions between treated and comparators, with death as a competing risk. In sensitivity analyses, we implemented inverse probability of censoring weights to account for censoring due to cross-over to treatment among comparators during follow-up.

Data sources and analytic sample: Data sources included the VA Vital Status File, VA Corporate Data Warehouse, and Centers for Medicare and Medicaid Services administrative files. Participants included 31,614 treated and 99,634 comparator high-risk Veterans initially hospitalized in fiscal year 2021.

Principal findings: Participants were primarily male sex, ≥ 65 years of age, and had initial hospitalizations in VA facilities; 15.9% and 2.3% of treated Veterans had 30-day all-cause and ACSC readmissions, respectively, compared with 13.5% and 2.1% of comparators. After accounting for the competing risk of death and covariates that remained imbalanced across groups after matching, post-hospitalization care coordination was associated with no difference in the risk of 30-day all-cause (aSHR 1.03, 95% CI 1.00, 1.07) and ACSC (aSHR 0.97, 95% CI 0.89, 1.05) readmission among high-risk Veterans. The risk of ACSC readmission was similar after including censoring weights (aSHR 1.00, 95% CI 0.92, 1.09); the increased risk of all-cause readmission was small in magnitude but statistically significant (aSHR 1.09, 95% CI 1.05, 1.13).

Conclusions: Receipt of post-hospitalization care coordination was largely associated with no difference in 30-day readmission risk, suggesting that alternative or additional services may be needed to address readmissions among high-risk Veterans.

目的:探讨住院和/或死亡风险高的退伍军人住院后护理协调与va交付、va购买和Medicare按服务收费再入院之间的关系。研究背景和设计:在这项观察性回顾性队列研究中,我们比较了出院后一天内接受护理协调的高风险退伍军人(“治疗”)和多达5名在此期间未接受护理协调的匹配高风险退伍军人(“比较者”)。竞争风险模型估计了治疗组和比较组之间30天全因和门诊敏感状况(ACSC)再入院的调整亚危险比(aSHR),其中死亡为竞争风险。在敏感性分析中,我们实施了审查权值的逆概率,以解释由于随访期间比较者之间的交叉治疗而导致的审查。数据源和分析样本:数据源包括VA重要状态文件、VA公司数据仓库以及医疗保险和医疗补助服务中心的管理文件。参与者包括31,614名接受治疗的退伍军人和99,634名比较高风险退伍军人,最初在2021财政年度住院。主要发现:参与者主要为男性,年龄≥65岁,在退伍军人管理局设施初次住院;15.9%和2.3%接受治疗的退伍军人分别有30天的全因和ACSC再入院,而对照组的这一比例分别为13.5%和2.1%。在考虑了匹配后各组间仍然不平衡的死亡竞争风险和协变量后,住院后护理协调与高风险退伍军人30天全因再入院风险(aSHR 1.03, 95% CI 1.00, 1.07)和ACSC (aSHR 0.97, 95% CI 0.89, 1.05)无差异相关。纳入审查权后,ACSC再入院的风险相似(aSHR 1.00, 95% CI 0.92, 1.09);全因再入院的风险增加幅度不大,但具有统计学意义(aSHR 1.09, 95% CI 1.05, 1.13)。结论:接受住院后护理协调在很大程度上与30天再入院风险无差异相关,这表明可能需要替代或额外的服务来解决高风险退伍军人的再入院问题。
{"title":"Risk of Hospital Readmissions and Association With Receipt of Post-Hospitalization Care Coordination Services Among High-Risk Veterans.","authors":"Diana J Govier, Meike Niederhausen, Alex Hickok, Mazhgan Rowneki, Holly McCready, Abby Moss, Kristina M Cordasco, Kathryn M McDonald, Matthew L Maciejewski, Kathleen C Thomas, Denise M Hynes","doi":"10.1111/1475-6773.70044","DOIUrl":"10.1111/1475-6773.70044","url":null,"abstract":"<p><strong>Objective: </strong>To examine associations between receipt of post-hospitalization care coordination and VA-delivered, VA-purchased, and Medicare fee-for-service hospital readmissions among Veterans at high risk for hospitalization and/or mortality.</p><p><strong>Study setting and design: </strong>In this observational retrospective cohort study, we compared high-risk Veterans who received care coordination within one day after hospital discharge (\"treated\") with up to five matched high-risk Veterans who did not receive care coordination during this time (\"comparators\"). Competing risk models estimated adjusted sub-hazard ratios (aSHR) for 30-day all-cause and ambulatory care sensitive condition (ACSC) readmissions between treated and comparators, with death as a competing risk. In sensitivity analyses, we implemented inverse probability of censoring weights to account for censoring due to cross-over to treatment among comparators during follow-up.</p><p><strong>Data sources and analytic sample: </strong>Data sources included the VA Vital Status File, VA Corporate Data Warehouse, and Centers for Medicare and Medicaid Services administrative files. Participants included 31,614 treated and 99,634 comparator high-risk Veterans initially hospitalized in fiscal year 2021.</p><p><strong>Principal findings: </strong>Participants were primarily male sex, ≥ 65 years of age, and had initial hospitalizations in VA facilities; 15.9% and 2.3% of treated Veterans had 30-day all-cause and ACSC readmissions, respectively, compared with 13.5% and 2.1% of comparators. After accounting for the competing risk of death and covariates that remained imbalanced across groups after matching, post-hospitalization care coordination was associated with no difference in the risk of 30-day all-cause (aSHR 1.03, 95% CI 1.00, 1.07) and ACSC (aSHR 0.97, 95% CI 0.89, 1.05) readmission among high-risk Veterans. The risk of ACSC readmission was similar after including censoring weights (aSHR 1.00, 95% CI 0.92, 1.09); the increased risk of all-cause readmission was small in magnitude but statistically significant (aSHR 1.09, 95% CI 1.05, 1.13).</p><p><strong>Conclusions: </strong>Receipt of post-hospitalization care coordination was largely associated with no difference in 30-day readmission risk, suggesting that alternative or additional services may be needed to address readmissions among high-risk Veterans.</p>","PeriodicalId":55065,"journal":{"name":"Health Services Research","volume":" ","pages":"e70044"},"PeriodicalIF":3.2,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12857460/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145180458","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Screening for Rate of Ghost Physicians in Provider Directories. 筛选供应商目录中幽灵医生的比率。
IF 3.2 2区 医学 Q2 HEALTH CARE SCIENCES & SERVICES Pub Date : 2026-02-01 DOI: 10.1111/1475-6773.70089
Jianhui Xu, Daniel Polsky

Objective: To provide a conceptual framework for understanding ghost networks and propose a new methodology for estimating ghost physician prevalence in health plans' provider directories.

Study setting and design: We focused on providers listed as primary care physicians in Medicare Advantage (MA) plans' provider directories. Our framework categorizes ghost PCPs into general ghosts-those listed as PCPs but unavailable to any Medicare beneficiaries for primary care-and network-specific ghosts-those available to Medicare beneficiaries but inaccessible to enrollees with a certain MA network. We identified general ghosts with multiple data sources. In estimating network-specific ghost prevalence, to separate those who were truly unavailable from those who were accessible but saw no patients simply due to chance, we estimated a logistic model predicting being low-volume among the zero-volume and low-volume PCP-networks.

Data sources and analytic sample: We used the 2019 Ideon MA provider directory data. For physician information, we used the National Plan and Provider Enumeration System National Provider Identifier registry and OneKey Healthcare Industry Database. To estimate the patient volume of listed PCPs, we extracted from the 2019 MA encounter data carrier file beneficiaries' primary care visits to physicians in the office, hospital outpatient, or clinic setting.

Principal findings: We found that 17.5% of the listed PCPs in an average MA network were general ghosts and 11.5% were network-specific ghosts. Health maintenance organization networks listed more ghost PCPs than preferred provider organization (30.5% vs. 26.9%). Networks associated with high star rating contracts had substantially fewer ghost PCPs than those associated with low star rating contracts (26.5% vs. 37.2%). Our methodology for screening for ghost prevalence reduces the penalty on networks offering more choice, such as those serving urban markets.

Conclusions: Policymakers should ensure that provider directories reflect the physicians available to provide care. Our methodology may facilitate targeted network audits.

目的:为理解幽灵网络提供一个概念框架,并提出一种估算健康计划提供者目录中幽灵医生流行率的新方法。研究设置和设计:我们关注的是医疗保险优势(MA)计划提供者目录中列出的初级保健医生。我们的框架将幽灵pcp分为一般幽灵和网络特定幽灵,前者被列为pcp,但对任何初级保健医疗保险受益人都无效,后者对医疗保险受益人有效,但对具有特定医疗保险网络的参保人无效。我们用多个数据源识别出一般的鬼影。在估计网络特定的幽灵患病率时,为了将那些真正不可用的人与那些可访问的人分开,但由于偶然原因没有看到病人,我们估计了一个逻辑模型,预测在零容量和低容量的pcp网络中是低容量的。数据来源和分析样本:我们使用2019年Ideon MA提供商目录数据。对于医生信息,我们使用了国家计划和提供者枚举系统国家提供者标识注册和OneKey医疗保健行业数据库。为了估计所列pcp的患者数量,我们从2019年MA遭遇数据载体文件中提取了受益人在办公室、医院门诊或诊所就诊的初级保健就诊情况。主要发现:我们发现在平均MA网络中列出的pcp中有17.5%是一般鬼,11.5%是网络特定鬼。健康维护组织网络比首选提供者组织列出了更多的幽灵pcp(30.5%比26.9%)。与低星级合同相关的网络相比,与高星级合同相关的网络拥有更少的幽灵pcp (26.5% vs 37.2%)。我们筛选幽灵流行的方法减少了对提供更多选择的网络的惩罚,例如那些服务于城市市场的网络。结论:决策者应确保提供者目录反映可提供护理的医生。我们的方法可以促进有针对性的网络审计。
{"title":"Screening for Rate of Ghost Physicians in Provider Directories.","authors":"Jianhui Xu, Daniel Polsky","doi":"10.1111/1475-6773.70089","DOIUrl":"10.1111/1475-6773.70089","url":null,"abstract":"<p><strong>Objective: </strong>To provide a conceptual framework for understanding ghost networks and propose a new methodology for estimating ghost physician prevalence in health plans' provider directories.</p><p><strong>Study setting and design: </strong>We focused on providers listed as primary care physicians in Medicare Advantage (MA) plans' provider directories. Our framework categorizes ghost PCPs into general ghosts-those listed as PCPs but unavailable to any Medicare beneficiaries for primary care-and network-specific ghosts-those available to Medicare beneficiaries but inaccessible to enrollees with a certain MA network. We identified general ghosts with multiple data sources. In estimating network-specific ghost prevalence, to separate those who were truly unavailable from those who were accessible but saw no patients simply due to chance, we estimated a logistic model predicting being low-volume among the zero-volume and low-volume PCP-networks.</p><p><strong>Data sources and analytic sample: </strong>We used the 2019 Ideon MA provider directory data. For physician information, we used the National Plan and Provider Enumeration System National Provider Identifier registry and OneKey Healthcare Industry Database. To estimate the patient volume of listed PCPs, we extracted from the 2019 MA encounter data carrier file beneficiaries' primary care visits to physicians in the office, hospital outpatient, or clinic setting.</p><p><strong>Principal findings: </strong>We found that 17.5% of the listed PCPs in an average MA network were general ghosts and 11.5% were network-specific ghosts. Health maintenance organization networks listed more ghost PCPs than preferred provider organization (30.5% vs. 26.9%). Networks associated with high star rating contracts had substantially fewer ghost PCPs than those associated with low star rating contracts (26.5% vs. 37.2%). Our methodology for screening for ghost prevalence reduces the penalty on networks offering more choice, such as those serving urban markets.</p><p><strong>Conclusions: </strong>Policymakers should ensure that provider directories reflect the physicians available to provide care. Our methodology may facilitate targeted network audits.</p>","PeriodicalId":55065,"journal":{"name":"Health Services Research","volume":"61 1","pages":"e70089"},"PeriodicalIF":3.2,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12875720/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146127646","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinician Specialization in Skilled Nursing Facility Practice and Post-Acute Outcomes of Patients With Dementia. 临床医生专业化的熟练护理设施实践和急性痴呆患者的预后。
IF 3.2 2区 医学 Q2 HEALTH CARE SCIENCES & SERVICES Pub Date : 2026-02-01 Epub Date: 2025-08-31 DOI: 10.1111/1475-6773.70035
Seiyoun Kim, Hye-Young Jung, Derek Lake, Rebecca T Brown, Rachel M Werner, Jason Karlawish, Kira Ryskina

Objective: To evaluate the effects of physician and advanced practitioner specialization in skilled nursing facility (SNF)-based practice (SNFists) on the outcomes of patients with Alzheimer's disease and related dementias (ADRD) admitted to SNF for post-acute care.

Study setting and design: Taking advantage of the natural experiment provided by the growth of SNFists, we conducted a within-SNF difference-in-differences analysis with cross-temporal matching. Our primary outcome was functional improvement at SNF discharge, measured using a validated activities of daily living (ADL) score. Secondary outcomes included unplanned rehospitalization, emergency department (ED) visits, observational stays within 30 days of SNF admission, successful discharge to the community, SNF length of stay, admission into long-term nursing home care within 6 months of SNF discharge, and 30- and 60-day Medicare payments for professional and facility services.

Data sources and analytic sample: Medicare facility and professional claims and Nursing Home Minimum Data Set (MDS) data from 2012 and 2019 were used. The study sample included 338,574 community-dwelling fee-for-service Medicare beneficiaries with ADRD, age 65 or older, discharged from an acute care hospital to one of the 5196 SNFs that experienced an increase in patients treated by SNFists.

Principal findings: We did not observe an association between SNFist care and patient post-acute care outcomes or costs.

Conclusions: Specialization in SNF-based practice among physicians and advanced practitioners alone may not be an effective strategy to improve post-acute care outcomes or reduce costs to Medicare for patients with ADRD.

目的:评价医师和高级执业医师专业化在熟练护理机构(SNF)为基础的实践(SNFists)对入住SNF进行急性后护理的阿尔茨海默病及相关痴呆(ADRD)患者预后的影响。研究设置与设计:利用snfist生长提供的自然实验条件,我们进行了跨时间匹配的snf内差异中差异分析。我们的主要结局是SNF出院时的功能改善,使用经过验证的日常生活活动(ADL)评分进行测量。次要结果包括意外再住院、急诊就诊、SNF入院后30天内的观察住院、成功出院、SNF住院时间、SNF出院后6个月内进入长期养老院护理、30天和60天的医疗保险支付专业和设施服务。数据来源和分析样本:使用2012年和2019年的医疗保险设施和专业索赔以及养老院最低数据集(MDS)数据。研究样本包括338,574名社区居住的ADRD的按服务收费的医疗保险受益人,年龄在65岁或以上,从急症护理医院出院到5196个snf之一,SNFists治疗的患者增加。主要发现:我们没有观察到snfirst护理与患者急性后护理结果或成本之间的关联。结论:医生和高级从业人员在snf基础上的实践专业化可能不是改善急性后护理结果或降低ADRD患者医疗保险成本的有效策略。
{"title":"Clinician Specialization in Skilled Nursing Facility Practice and Post-Acute Outcomes of Patients With Dementia.","authors":"Seiyoun Kim, Hye-Young Jung, Derek Lake, Rebecca T Brown, Rachel M Werner, Jason Karlawish, Kira Ryskina","doi":"10.1111/1475-6773.70035","DOIUrl":"10.1111/1475-6773.70035","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the effects of physician and advanced practitioner specialization in skilled nursing facility (SNF)-based practice (SNFists) on the outcomes of patients with Alzheimer's disease and related dementias (ADRD) admitted to SNF for post-acute care.</p><p><strong>Study setting and design: </strong>Taking advantage of the natural experiment provided by the growth of SNFists, we conducted a within-SNF difference-in-differences analysis with cross-temporal matching. Our primary outcome was functional improvement at SNF discharge, measured using a validated activities of daily living (ADL) score. Secondary outcomes included unplanned rehospitalization, emergency department (ED) visits, observational stays within 30 days of SNF admission, successful discharge to the community, SNF length of stay, admission into long-term nursing home care within 6 months of SNF discharge, and 30- and 60-day Medicare payments for professional and facility services.</p><p><strong>Data sources and analytic sample: </strong>Medicare facility and professional claims and Nursing Home Minimum Data Set (MDS) data from 2012 and 2019 were used. The study sample included 338,574 community-dwelling fee-for-service Medicare beneficiaries with ADRD, age 65 or older, discharged from an acute care hospital to one of the 5196 SNFs that experienced an increase in patients treated by SNFists.</p><p><strong>Principal findings: </strong>We did not observe an association between SNFist care and patient post-acute care outcomes or costs.</p><p><strong>Conclusions: </strong>Specialization in SNF-based practice among physicians and advanced practitioners alone may not be an effective strategy to improve post-acute care outcomes or reduce costs to Medicare for patients with ADRD.</p>","PeriodicalId":55065,"journal":{"name":"Health Services Research","volume":" ","pages":"e70035"},"PeriodicalIF":3.2,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12668470/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144979391","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
From Criticism to Comfort: The Relational Benefits of Long-Term Care Insurance. 从批评到安慰:长期护理保险的相关利益。
IF 3.2 2区 医学 Q2 HEALTH CARE SCIENCES & SERVICES Pub Date : 2026-02-01 Epub Date: 2025-08-13 DOI: 10.1111/1475-6773.70026
Xianhua Zai

Objectives: The objective of this study is to examine whether potentially eligible individuals with Partnership Long-Term Care Insurance (PLTCI) program experience stronger social networks and improved interpersonal relationships compared to those without coverage.

Study setting and design: Our analysis utilizes data from the Health and Retirement Study (HRS), a longitudinal survey of U.S. adults aged 50 and older, incorporating responses from the Leave-Behind Questionnaire administered biennially from 2004 to 2018. We merge these data with a dataset tracking state-level implementation of the PLTCI program, enabling us to construct a binary indicator of policy exposure based on respondents' state of residence. Using ordinary least squares (OLS) regression with two-way fixed effects, we estimate the effect of the PLTCI program on the relational outcomes of aging individuals.

Data sources and analytic sample: The analytic sample includes HRS respondents potentially eligible for the PLTCI program at the time of its implementation, focusing on respondents and their spouse no more than 65 years without physical limitations per Activities of Daily Living (ADL) criteria. Depending on data availability, the sample size ranges from approximately 13,000 to 17,000 participants.

Principal findings: The PLTCI program improved perceived relationships with children and spouses. Older adults reported less frequent criticism (4.3% decrease with children, p = 0.04, 95% CI: 0.3%-8.3%; 3.4% with spouse, p = 0.04), feeling let down (3.9% decrease with children, p = 0.01; 3.8% with spouse, p = 0.009), or being annoyed (3.5% decrease with children, p = 0.03). They also felt more comfortable opening up about worries (2.1% increase with children) and relying on close family members during serious problems (3.0% increase with children, p = 0.01). These effects were strongest among individuals aged 55 and older compared to younger individuals, non-Hispanic White respondents compared to non-Hispanic Black respondents, and those with higher household wealth compared to those with lower household wealth.

Conclusions: Beyond financial security, the PLTCI program enhances older adults' social and emotional well-being by improving close relationships. These findings highlight the need to consider both economic and relational outcomes when evaluating long-term care policies.

目的:本研究的目的是检验是否潜在的符合条件的个人与伙伴关系长期护理保险(PLTCI)计划相比,有更强的社会网络和改善的人际关系。研究设置和设计:我们的分析利用了健康与退休研究(HRS)的数据,这是一项对50岁及以上的美国成年人进行的纵向调查,其中包括2004年至2018年每两年进行一次的“留守问卷”的回答。我们将这些数据与跟踪PLTCI计划在州一级实施的数据集合并,使我们能够基于受访者的居住状态构建政策敞口的二元指标。采用双向固定效应的普通最小二乘(OLS)回归,我们估计了PLTCI计划对衰老个体相关结果的影响。数据来源和分析样本:分析样本包括在实施PLTCI计划时可能符合条件的HRS受访者,重点关注受访者及其配偶不超过65岁,根据日常生活活动(ADL)标准没有身体限制。根据数据的可用性,样本量约为13,000至17,000名参与者。主要发现:PLTCI项目改善了与子女和配偶的感知关系。老年人报告的批评频率较低(儿童减少4.3%,p = 0.04, 95% CI: 0.3%-8.3%;有配偶的3.4%,p = 0.04),感到失望(有子女的3.9%下降,p = 0.01;3.8%与配偶相处,p = 0.009),或被惹恼(与孩子相处减少3.5%,p = 0.03)。她们也更愿意敞开心扉倾诉忧虑(有孩子时增加2.1%),在遇到严重问题时更愿意依靠亲密的家庭成员(有孩子时增加3.0%,p = 0.01)。与年轻人相比,55岁及以上的人,非西班牙裔白人受访者与非西班牙裔黑人受访者相比,家庭财富较高的人与家庭财富较低的人相比,这些影响最为明显。结论:除了经济安全,PLTCI计划还通过改善亲密关系来提高老年人的社会和情感健康。这些发现强调了在评估长期护理政策时需要同时考虑经济和相关结果。
{"title":"From Criticism to Comfort: The Relational Benefits of Long-Term Care Insurance.","authors":"Xianhua Zai","doi":"10.1111/1475-6773.70026","DOIUrl":"10.1111/1475-6773.70026","url":null,"abstract":"<p><strong>Objectives: </strong>The objective of this study is to examine whether potentially eligible individuals with Partnership Long-Term Care Insurance (PLTCI) program experience stronger social networks and improved interpersonal relationships compared to those without coverage.</p><p><strong>Study setting and design: </strong>Our analysis utilizes data from the Health and Retirement Study (HRS), a longitudinal survey of U.S. adults aged 50 and older, incorporating responses from the Leave-Behind Questionnaire administered biennially from 2004 to 2018. We merge these data with a dataset tracking state-level implementation of the PLTCI program, enabling us to construct a binary indicator of policy exposure based on respondents' state of residence. Using ordinary least squares (OLS) regression with two-way fixed effects, we estimate the effect of the PLTCI program on the relational outcomes of aging individuals.</p><p><strong>Data sources and analytic sample: </strong>The analytic sample includes HRS respondents potentially eligible for the PLTCI program at the time of its implementation, focusing on respondents and their spouse no more than 65 years without physical limitations per Activities of Daily Living (ADL) criteria. Depending on data availability, the sample size ranges from approximately 13,000 to 17,000 participants.</p><p><strong>Principal findings: </strong>The PLTCI program improved perceived relationships with children and spouses. Older adults reported less frequent criticism (4.3% decrease with children, p = 0.04, 95% CI: 0.3%-8.3%; 3.4% with spouse, p = 0.04), feeling let down (3.9% decrease with children, p = 0.01; 3.8% with spouse, p = 0.009), or being annoyed (3.5% decrease with children, p = 0.03). They also felt more comfortable opening up about worries (2.1% increase with children) and relying on close family members during serious problems (3.0% increase with children, p = 0.01). These effects were strongest among individuals aged 55 and older compared to younger individuals, non-Hispanic White respondents compared to non-Hispanic Black respondents, and those with higher household wealth compared to those with lower household wealth.</p><p><strong>Conclusions: </strong>Beyond financial security, the PLTCI program enhances older adults' social and emotional well-being by improving close relationships. These findings highlight the need to consider both economic and relational outcomes when evaluating long-term care policies.</p>","PeriodicalId":55065,"journal":{"name":"Health Services Research","volume":" ","pages":"e70026"},"PeriodicalIF":3.2,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12857447/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144849689","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Health Services Research
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1